Baric­i­tinib phos­phate CAS 1187595-84-1

Iden­ti­fi­ca­tion Prop­er­ties Safe­ty Data Spec­i­fi­ca­tions andamp ; Oth­er Information Links

Iden­ti­fi­ca­tion

CAS Number

1187595-84-1

Name

Baric­i­tinib phos­phate

Syn­onyms

{1-(Ethylsulfonyl)-3-[4-(1H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidinyl}acetonitrile phos­phate (1:1) [ACD/IUPAC Name] 3-Aze­­tidineace­­toni­trile, 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-, phos­phate (1:1) [ACD/​Index Name] Acide phos­pho­rique – {1-(éthylsulfonyl)-3-[4-(1H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azétidinyl}acétonitrile (1:1) [French] [ACD/IUPAC Name] Phos­pho­rsäure –{1-(ethylsulfonyl)-3-[4-(1H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidinyl}acetonitril (1:1) [Ger­man] [ACD/IUPAC Name] [1187595-84-1] 1187595-84-1 [RN] 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile phos­phate Baric­i­tinib (ly3009104, incb028050) Baric­i­tinib (phos­phate) Baric­i­tinib phos­phate INCB 028050 INCB 028050 ;LY 3009104 ;INCB028050 ;LY3009104 ;LY-3009104 ;INCB-028050 INCB028050 INCB-028050 INCB424-Ana­­logue LY 3009104 LY3009104 LY-3009104 MFCD25976707 Phos­phor­ic acid – {1-(ethanesulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}acetonitrile (1/1)

Mol­e­c­u­lar Structure

SMILES

CCS(=O)(=O)N1CC(C1)(CC#N)n2cc(cn2)c3c4cc[nH]c4ncn3.OP(=O)(O)O

Std­InChI

InChI=1S/C16H17N7O2S.H3O4P/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14;1-5(2,3)4/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20);(H3,1,2,3,4)

Std­InChIKey

FBPOWT­F­­FUB­BKBB-UHF­F­­FAOYSA-N

Mol­e­c­u­lar Formula

C16H20N7O6PS

Mol­e­c­u­lar Weight

469.412

Prop­er­ties

Appear­ance

Off-white to white pow­der

Safe­ty Data

WGK Germany

3 

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our Baric­i­tinib phos­phate CAS 1187595-84-1

Stan­dard

Enter­prise stan­dard

Iden­ti­fi­ca­tion Methods

HPLC

Puri­ty

99%min

Loss on Drying

≤0.5%

Sin­gle Impurity

≤0.1%

Total Impu­ri­ties

≤0.5%

Pack­age

Accord­ing to cus­tomer require­ments to pack­ag­ing

Stor­age

Store at room tem­per­a­ture for a long time, sealed and keep in a dry place.

Shelf life

2 Years

Appli­ca­tion

Com­mon­ly used as anti-can­cer and anti-tumor drugs

Oth­er forms

Baric­i­tinib CAS 1187594-09-7

Gen­er­al View of Documents

Links

This prod­uct is devel­oped by our RD com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Ltd(http://​www​.cam​ing​.com/), and here is the cor­re­spond­ing linkhttp://​www​.cam​ing​.com/​b​a​r​i​c​i​t​i​n​i​b​-​p​h​o​s​p​h​a​t​e​-​c​a​s​-​1​1​8​7​5​9​5​-​8​4​-1/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you short­ly (Please change screen to hor­i­zon­tal for com­plete brows­ing if you are check­ing Wat­son on your mobile phone).